XML 52 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Collaboration Agreements, License Agreement and Revenues - Eluminex Agreement - Additional Information 2 (Detail) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Jul. 31, 2021
Mar. 31, 2023
Mar. 31, 2022
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]      
Total revenue   $ 36,161 $ 60,827
Eluminex [Member]      
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]      
Aggregate consideration received for milestone and upfront payments $ 8,000    
Future manufacturing clinical regulatory and commercial milestone payments 64,000    
Commercial milestone $ 36,000    
Eluminex [Member] | Cornea Products [Member]      
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]      
Percentage of product manufacturing costs until manufacturing technology fully transferred     10.00%
China [Member] | Eluminex [Member] | Biosynthetic Cornea [Member]      
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]      
Milestone Payments   3,000  
Manufacturing related milestone payments   $ 3,000